IP Library Granted Patent US 8,753,858
Granted Patent B2
US 8,753,858 · App. 12/980,870 · Granted Jun 17, 2014

Reagents and processes for stabilizing alkaline phosphatase or conjugates thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,753,858
App. No.
12/980,870
Granted
Jun 17, 2014
Kind
B2
Abstract

The present disclosure relates to stabilizers for alkaline phosphatase or conjugates thereof, a process for preparing a stabilizer, and a method for stabilizing alkaline phosphatase or conjugates thereof with a stabilizer. The present disclosure also relates to a reagent of alkaline phosphatase or conjugates thereof as well as to a process for preparing the same. In another aspect, the present disclosure relates to a kit comprising the stabilizers disclosed herein and alkaline phosphatase or conjugates thereof. The stabilizer disclosed herein can stabilize alkaline phosphatase or conjugates thereof for a prolonged period of time, extending their shelf-life.

Claims (42)

1. A method for stabilizing alkaline phosphatase or a conjugate thereof, the method comprising:

mixing alkaline phosphatase or a conjugate thereof with an aqueous alkaline phosphatase stabilizer solution;

wherein the aqueous alkaline phosphatase stabilizer solution comprises:

a protein selected from at least one of the following: albumin, casein, and gelatin;

magnesium and calcium ions, wherein the magnesium and calcium ions together have a concentration in the range of between about 0.001 and about 0.01mol/L;

zinc ions, wherein the zinc ions have a concentration in the range of between about 0.01 and about 0.2 mmol/L; and

sodium ions, wherein the sodium ions have a concentration in the range of between about 0.5 and about 3.0 mol/L.

2. The method of claim 1 , wherein the sodium ions in the aqueous alkaline phosphatase stabilizer solution are derived from sodium chloride.

3. The method of claim 2 , wherein the aqueous alkaline phosphatase stabilizer solution contains from about 30 g/L to about 175 g/L of sodium chloride.

4. The method of claim 1 , wherein the aqueous alkaline phosphatase stabilizer solution further comprises one or more protectant, wherein the one or more protectant is selected from at least one of the following: a polyol, a saccharide, a surfactant and a polyethylene glycol.

5. The method of claim 4 , wherein the polyol is selected from at least one of the following: glycerol, mannitol, sorbitol, inositol and xylitol.

6. The method of claim 4 , wherein the saccharide is selected from at least one of the following: galactose, lactose, fructose, sucrose, and trehalose.

7. The method of claim 4 , wherein the surfactant is a nonionic surfactant.

8. The method of claim 7 , wherein the nonionic surfactant is either a sorbitan polyoxyethylene ether fatty acid ester or an alkylphenol polyoxyethylene ether.

9. The method of claim 8 , wherein the sorbitan polyoxyethylene ether fatty acid ester is either a sorbitan polyoxyethylene ether lauric acid ester or a sorbitan polyoxyethylene ether oleic acid ester.

10. The method of claim 8 , wherein the alkylphenol polyoxyethylene ether is an octylphenol polyoxyethylene ether.

11. The method of claim 4 , wherein the polyethylene glycol has a molecular weight ranging from about 6,000 to about 20,000.

12. The method of claim 11 , wherein the polyethylene glycol has a molecular weight of about 20,000.

13. The method of claim 1 , wherein the aqueous alkaline phosphatase stabilizer solution further comprises a buffering agent.

14. The method of claim 1 , wherein the aqueous alkaline phosphatase stabilizer solution further comprises a protease inhibitor.

15. A process for preparing a reagent of alkaline phosphatase or a conjugate thereof, the process comprising:

mixing or dissolving alkaline phosphatase or a conjugate thereof in an aqueous alkaline phosphatase stabilizer solution;

wherein the aqueous alkaline phosphatase stabilizer solution comprises:

a protein selected from at least one of the following: albumin, casein, and gelatin;

magnesium and calcium ions, wherein the magnesium and

calcium ions together have a concentration in the range of between about 0.001 and about 0.01 mol/L;

zinc ions, wherein the zinc ions have a concentration in the range of between about 0.01 and about 0.2 mmol/L;

sodium ions, wherein the sodium ions have a concentration in the range of between about 0.5 and about 3.0 mol/L; and

a nonionic surfactant, wherein the nonionic surfactant is an octylphenol polyoxyethylene ether type surfactant that is present in a concentration in the range of

between about 0.1% and about 10% (w/v); and

optionally drying the solution into a powder.

16. A process for preparing a reagent of alkaline phosphatase or a conjugate thereof, the process comprising:

drying an aqueous alkaline phosphatase stabilizer solution to a powder;

drying an aqueous solution of alkaline phosphatase or a conjugate thereof to a powder; and

mixing the powders together;

wherein the aqueous alkaline phosphatase stabilizer solution comprises:

a protein selected from at least one of the following: albumin, casein and gelatin;

magnesium and calcium ions, wherein the magnesium and

calcium ions together have a concentration in the range of between about 0.001 and about 0.01 mol/L;

zinc ions, wherein the zinc ions have a concentration in the range of between about 0.01 and about 0.2 mmol/L;

sodium ions, wherein the sodium ions have a concentration in the range of between about 0.5 and about 3.0 mol/L; and

a combination of glycerol and mannitol, wherein the combined concentration of glycerol and mannitol is between about 5% and about 10% (w/v).

Assignments (3)
LICENSE Recorded Jun 24, 2022
From: SHENZHEN MINDRAY BIOMEDICAL ELECTRONICS CO., LTD.
To: SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
Reel/Frame 060440/0796 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE FIRST INVENTOR FROM CHEUGEN QIAN PREVIOUSLY RECORDED ON REEL 032765 FRAME 0754. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT NAME OF FIRST INVENTOR IS CHUNGEN QIAN. Recorded May 9, 2014
From: QIAN, CHUNGEN; ZHANG, YUPING
To: SHENZHEN MINDRAY BIO-MEDICAL ELEXTRONICS CO., LTD.
Reel/Frame 032860/0260 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2014
From: QIAN, CHEUGEN; ZHANG, YUPING
To: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Reel/Frame 032765/0754 →